David Kaetzel

Dr. David Kaetzel

Department of Biochemistry and Molecular Biology, Greenebaum Cancer Center, School of Medicine, University of Maryland-Baltimore, Baltimore, MD, USA
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Laboratory Investigation
Verified
Journal Article
Open access
PDF file
GPGemma S Puts
Gemma S Puts
MLM Kathryn Leonard
M Kathryn Leonard
NPNidhi V Pamidimukkala
Nidhi V Pamidimukkala
DSDevin E Snyder
Devin E Snyder
DKDavid Kaetzel
David Kaetzel
The NME family of proteins is composed of 10 isoforms, designated NME1-10, which are diverse in their enzymatic activities and patterns of subcellular localization. Each contains a conserved domain associated with a nucleoside diphosphate kinase (NDPK) function, although not all are catalytically active. Several of the NME isoforms (NME1, NME5, NME7, and NME8) also exhibit a 3′–5′ exonuclease activity, suggesting roles in DNA proofreading and repair. NME1 and NME2 have been shown to translocate to the nucleus, although they lack a canonical nuclear localization signal. Binding of NME1 and NME2 to DNA does not appear to be sequence-specific in a strict sense, but instead is directed to single-stranded regions and/or other non-B-form structures. NME1 and NME2 have been identified as potential canonical transcription factors that regulate gene transcription through their DNA-binding activities. Indeed, the NME1 and NME2 isoforms have been shown to regulate gene expression programs in a number of cellular settings, and this regulatory function has been proposed to underlie their well-recognized ability to suppress the metastatic phenotype of cancer cells. Moreover, NME1 and, more recently, NME3, have been implicated in repair of both single- and double-stranded breaks in DNA. This suggests that reduced expression of NME proteins could contribute to the genomic instability that drives cancer progression. Clearly, a better understanding of the nuclear functions of NME1 and possibly other NME isoforms could provide critical insights into mechanisms underlying malignant progression in cancer. Indeed, clinical data indicate that the subcellular localization of NME1 may be an important prognostic marker in some cancers. This review summarizes putative functions of nuclear NME proteins in DNA binding, transcription, and DNA damage repair, and highlights their possible roles in cancer progression.

1 July 2014
Verified
Journal Article
Closed access
JMJoseph R. Mccorkle
Joseph R. Mccorkle
MLMary K. Leonard
Mary K. Leonard
SKSusan D. Kraner
Susan D. Kraner
EBEric M. Blalock
Eric M. Blalock
DMDeqin Ma
Deqin Ma
DKDavid Kaetzel
David Kaetzel

1 August 2019 in Molecular Cancer Research
Verified
Journal Article
Closed access
PDF file
YWYing Wang
Ying Wang
MLM. Kathryn Leonard
M. Kathryn Leonard
DSDevin E. Snyder
Devin E. Snyder
MFMatthew L. Fisher
Matthew L. Fisher
RERichard L. Eckert
Richard L. Eckert
DKDavid Kaetzel
David Kaetzel
Melanoma is a lethal skin cancer prone to progression and metastasis, and resistant to therapy. Metastasis and therapy resistance of melanoma and other cancers are driven by tumor cell plasticity, largely via acquisition/loss of stem-like characteristics and transitions between epithelial and mesenchymal phenotypes (EMT/MET). NME1 is a metastasis suppressor gene that inhibits metastatic potential when its expression is enforced in melanoma and other cancers. Herein, we have unmasked a novel role for NME1 as a driver of melanoma growth distinct from its canonical function as a metastasis suppressor. NME1 promotes expansion of stem-like melanoma cells that exhibit elevated expression of stem cell markers (e.g., Sox2, Sox10, Oct-4, KLF4, and Ccnb-1), enhanced growth as melanoma spheres in culture, and enhanced tumor growth and lung colonizing activities in vivo. In contrast, NME1 expression did not affect the proliferation of melanoma cell lines in monolayer culture conditions. Silencing of NME1 expression resulted in a dramatic reduction in melanoma sphere size, and impaired tumor growth and metastatic activities of melanoma sphere cells when xenografted in immunocompromised mice. Individual cells within melanoma sphere cultures displayed a wide range of NME1 expression across multiple melanoma cell lines. Cell subpopulations with elevated NME1 expression were fast cycling and displayed enhanced expression of stem cell markers. Implications: Our findings suggest the current model of NME1 as a metastasis-suppressing factor requires refinement, bringing into consideration its heterogeneous expression within melanoma sphere cultures and its novel role in promoting the expansion and tumorigenicity of stem-like cells.

23 October 2017 in Laboratory Investigation
Verified
Journal Article
Closed access
PDF file
MLM Kathryn Leonard
M Kathryn Leonard
JMJoseph R McCorkle
Joseph R McCorkle
DSDevin E Snyder
Devin E Snyder
MNMarian Novak
Marian Novak
QZQingbei Zhang
Qingbei Zhang
DKDavid Kaetzel
David Kaetzel

1 December 1998 in Journal of Biological Chemistry
Verified
Journal Article
Open access
RMRaymond S. Maul
Raymond S. Maul
HZHong-Xing Zhang
Hong-Xing Zhang
JRJames D. Reid
James D. Reid
NPNancy G. Pedigo
Nancy G. Pedigo
DKDavid Kaetzel
David Kaetzel
Transient transfection analysis of DNA subfragments from the distal 5'-flanking region of the human platelet-derived growth factor A-chain gene (-18.3 to -1.8 kilobase pairs (kb)) revealed enhancer and silencer elements that contribute significantly to transcriptional regulation. Two adjacent regions (-8.2 to -7.5 kb and -7.5 to -7.0 kb) enhanced transcription of both A-chain and heterologous thymidine kinase promoters, whereas repression was observed in two other nearby regions (-9.9 to -8.2 kb and -7.0 to -5. 9 kb). The -7.5 to -7.0-kb fragment, or J, was the strongest enhancer, and its activity was localized to a 66-base pair element (A-chain cell type-specific enhancer (ACE 66)). ACE66 activity was highly cell type-specific, with greatest activity seen in choriocarcinoma cell lines (4-10-fold enhancement). Progressive 5'- and 3'-deletions of the ACE66 revealed distribution of activity across the element, with nucleotides 1-33 being critical for function. Electrophoretic mobility shift assays revealed cell type-specific patterns of high affinity protein binding to the element. Ethylation interference footprinting of JEG-3 extract localized guanine contacts on nucleotides 1-18 of both strands of the ACE element, whereas more extensive contacts were made with the phosphate backbone (nucleotides 1-32). The ACE66 element is a potent transcriptional regulator in placental cells and represents a valuable model of long distance regulation in a growth factor gene.

1 January 2019 in Experimental Cell Research
Verified
Journal Article
Closed access
MLM. Kathryn Leonard
M. Kathryn Leonard
MNMarián Novak
Marián Novak
DSDevin Snyder
Devin Snyder
GSGrace Snow
Grace Snow
NPNidhi Pamidimukkala
Nidhi Pamidimukkala
DKDavid Kaetzel
David Kaetzel